Wockhardt seeks USFDA approval for Zidebactam-Cefepime injection to treat Serious GramNegative Infections
Mumbai: Wockhardt has announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (US FDA) for its novel antibacterial agent Zidebactam-Cefepime injection (WCK 5222, ZAYNICH).…
